000			02383 a2200649 4500
005			20250516215348.0
264		0	_c20140818
008			201408s 0 0 eng d
022			_a1474-547X
024	7		_a10.1016/S0140-6736(14)60538-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aManns, Michael
245	0	0	_aSimeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial. _h[electronic resource]
260			_bLancet (London, England) _cAug 2014
300			_a414-26 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHeterocyclic Compounds, 3-Ring _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols _xadministration & dosage
650	0	4	_aRecombinant Proteins _xadministration & dosage
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aSimeprevir
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aMarcellin, Patrick
700	1		_aPoordad, Fred
700	1		_ade Araujo, Evaldo Stanislau Affonso
700	1		_aButi, Maria
700	1		_aHorsmans, Yves
700	1		_aJanczewska, Ewa
700	1		_aVillamil, Federico
700	1		_aScott, Jane
700	1		_aPeeters, Monika
700	1		_aLenz, Oliver
700	1		_aOuwerkerk-Mahadevan, Sivi
700	1		_aDe La Rosa, Guy
700	1		_aKalmeijer, Ronald
700	1		_aSinha, Rekha
700	1		_aBeumont-Mauviel, Maria
773	0		_tLancet (London, England) _gvol. 384 _gno. 9941 _gp. 414-26
856	4	0	_uhttps://doi.org/10.1016/S0140-6736(14)60538-9 _zAvailable from publisher's website
999			_c23897753 _d23897753